Ibuprofen and the NSAID family explained

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medicines in the world. As the name suggests, they are a class of drugs that reduce inflammation, relieve pain, and lower fever without relying on steroids. Ibuprofen is perhaps the most recognisable member of this family, but the class also includes everyday medicines such as naproxen, diclofenac, and the much older acetylsalicylic acid, commonly known as aspirin. When used for conditions ranging from temporary headaches to chronic joint pain, these medicines share a common biological target in the human body.

How NSAIDs Work in the Body

NSAIDs produce their effects by interfering with the body's production of prostaglandins. Prostaglandins are hormone-like chemicals that promote inflammation, pain, and fever in response to injury or illness. They are manufactured by enzymes known as cyclooxygenases, which are usually abbreviated as COX. There are two primary forms of this enzyme: COX-1 and COX-2. COX-1 is constantly present in the body and helps maintain the protective mucosal lining of the stomach, while COX-2 is primarily produced in response to injury or infection.

Most traditional NSAIDs, including ibuprofen, block both COX-1 and COX-2. By inhibiting these enzymes, NSAIDs reduce the synthesis of prostaglandins, which in turn lowers inflammation and dampens pain signals. This dual action also explains why some individuals experience stomach discomfort or indigestion when taking these medicines, as the protective lining of the stomach can become vulnerable when COX-1 is blocked. Later generations of NSAIDs were developed to selectively target only the COX-2 enzyme to reduce stomach issues, though these carry their own distinct safety considerations.

The Discovery of Ibuprofen

Before ibuprofen was developed, aspirin was the primary anti-inflammatory drug available, but it frequently caused severe stomach irritation when used at the high doses required for inflammatory conditions. In the 1950s, researchers at the Boots Pure Drug Company in the United Kingdom, led by pharmacologist Dr Stewart Adams, began searching for a safer alternative to treat rheumatoid arthritis. They tested hundreds of chemical compounds over several years, looking for substances that reduced inflammation without causing significant gastrointestinal side effects.

The breakthrough came in 1961 when the team identified a compound from the phenylpropionic acid group, which would later be named ibuprofen. It was patented that same year and first introduced as a prescription treatment in the United Kingdom in the late 1960s. Ibuprofen proved highly effective and was notably better tolerated by patients than earlier alternatives. Over the subsequent decades, as its safety profile became well established through widespread use, it gradually transitioned to an over-the-counter medicine in many countries, becoming a staple of household medicine cabinets globally.

Over-the-Counter and Prescription Strengths

The regulatory status of NSAIDs varies significantly by country, often depending on the specific dosage, formulation, and intended duration of use. Generally, lower doses are available over-the-counter (OTC) for short-term management of pain and fever, while higher doses remain prescription-only for managing chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis. In the United Kingdom and the United States, for example, ibuprofen is widely sold in lower milligram strengths without a prescription, whereas higher strengths require a doctor's authorisation.

In South Africa, the scheduling of medicines is managed by the South African Health Products Regulatory Authority (SAHPRA). Depending on the dosage and whether the product is combined with other active ingredients, ibuprofen is categorised across different schedule tiers. Lower strengths may be sold as general sales list or schedule 2 pharmacy-only medicines, while higher strengths are restricted to schedule 3 or 4, requiring a prescription. This tiered scheduling approach is a common regulatory strategy globally, intended to balance public accessibility to pain relief with the need to minimise risks associated with higher doses.

The Generic Market and Global Availability

Because the original patents for ibuprofen and many other NSAIDs expired decades ago, the global market for these medicines is heavily genericised. Generic medicines contain the same active pharmaceutical ingredient as the original brand-name products and must meet the same stringent quality, safety, and efficacy standards. Today, ibuprofen and diclofenac are sold under dozens of brand names alongside their generic labels, driving down prices and making the medicines highly affordable.

The World Health Organization (WHO) includes ibuprofen on its Model List of Essential Medicines, recognising it as a core component of basic healthcare systems worldwide. Because these medicines are produced by multiple manufacturers globally, supply chains are generally very stable. Patients and healthcare providers can use tools like HealthSA to search for registered products and compare the Single Exit Price of specific ibuprofen formulations available in South Africa.